The global threat of antimicrobial resistance: science for intervention I Roca, M Akova, F Baquero, J Carlet, M Cavaleri, S Coenen, J Cohen, ... New microbes and new infections 6, 22-29, 2015 | 1376 | 2015 |
Bacterial infections in cirrhosis: epidemiological changes with invasive procedures and norfloxacin prophylaxis J Fernández, M Navasa, J Gómez, J Colmenero, J Vila, V Arroyo, J Rodés Hepatology 35 (1), 140-148, 2002 | 1360 | 2002 |
Bacterial infections in cirrhosis: a position statement based on the EASL Special Conference 2013 R Jalan, J Fernandez, R Wiest, B Schnabl, R Moreau, P Angeli, ... Journal of hepatology 60 (6), 1310-1324, 2014 | 1079 | 2014 |
Salmonella enterica serovar Typhimurium skills to succeed in the host: virulence and regulation A Fàbrega, J Vila Clinical microbiology reviews 26 (2), 308-341, 2013 | 1012 | 2013 |
Porins, efflux pumps and multidrug resistance in Acinetobacter baumannii J Vila, S Martí, J Sanchez-Céspedes Journal of antimicrobial chemotherapy 59 (6), 1210-1215, 2007 | 682 | 2007 |
Bacterial translocation of enteric organisms in patients with cirrhosis I Cirera, TM Bauer, M Navasa, J Vila, L Grande, P Taurá, J Fuster, ... Journal of hepatology 34 (1), 32-37, 2001 | 635 | 2001 |
Mechanisms of Resistance in Multiple-Antibiotic-Resistant Escherichia coli Strains of Human, Animal, and Food Origins Y Sáenz, L Brinas, E Domínguez, J Ruiz, M Zarazaga, J Vila, C Torres Antimicrobial agents and chemotherapy 48 (10), 3996-4001, 2004 | 621 | 2004 |
Fungal diversity notes 111–252—taxonomic and phylogenetic contributions to fungal taxa HA Ariyawansa, KD Hyde, SC Jayasiri, B Buyck, KWT Chethana, DQ Dai, ... Fungal diversity 75, 27-274, 2015 | 597 | 2015 |
Mechanism of action of and resistance to quinolones A Fàbrega, S Madurga, E Giralt, J Vila Microbial biotechnology 2 (1), 40-61, 2009 | 579 | 2009 |
Risk factors for community-onset urinary tract infections due to Escherichia coli harbouring extended-spectrum β-lactamases E Calbo, V Romaní, M Xercavins, L Gómez, CG Vidal, S Quintana, J Vila, ... Journal of Antimicrobial Chemotherapy 57 (4), 780-783, 2006 | 496 | 2006 |
The Acinetobacter baumannii Oxymoron: Commensal Hospital Dweller Turned Pan-Drug-Resistant Menace I Roca, P Espinal, X Vila-Farrés, J Vila Frontiers in microbiology 3, 148, 2012 | 492 | 2012 |
Immunogenicity and reactogenicity of BNT162b2 booster in ChAdOx1-S-primed participants (CombiVacS): a multicentre, open-label, randomised, controlled, phase 2 trial AM Borobia, AJ Carcas, M Pérez-Olmeda, L Castaño, MJ Bertran, ... The Lancet 398 (10295), 121-130, 2021 | 449 | 2021 |
Escherichia coli: an old friend with new tidings J Vila, E Sáez-López, JR Johnson, U Römling, U Dobrindt, R Cantón, ... FEMS microbiology reviews 40 (4), 437-463, 2016 | 437 | 2016 |
Effect of biofilm formation on the survival of Acinetobacter baumannii on dry surfaces P Espinal, S Martí, J Vila Journal of Hospital Infection 80 (1), 56-60, 2012 | 412 | 2012 |
Biofilm formation in Acinetobacter baumannii: associated features and clinical implications J Rodríguez‐Baño, S Marti, S Soto, F Fernández‐Cuenca, JM Cisneros, ... Clinical microbiology and infection 14 (3), 276-278, 2008 | 360 | 2008 |
Antioxidant effect of virgin olive oil in patients with stable coronary heart disease: a randomized, crossover, controlled, clinical trial M Fitó, M Cladellas, R De La Torre, J Marti, M Alcántara, ... Atherosclerosis 181 (1), 149-158, 2005 | 338 | 2005 |
Guidelines for the prevention and treatment of travelers’ diarrhea: a graded expert panel report MS Riddle, BA Connor, NJ Beeching, HL DuPont, DH Hamer, P Kozarsky, ... Journal of travel medicine 24 (suppl_1), S63-S80, 2017 | 325 | 2017 |
Association between double mutation in gyrA gene of ciprofloxacin-resistant clinical isolates of Escherichia coli and MICs J Vila, J Ruiz, F Marco, A Barcelo, P Goni, E Giralt, T Jimenez de Anta Antimicrobial agents and chemotherapy 38 (10), 2477-2479, 1994 | 316 | 1994 |
Mutation in the gyrA gene of quinolone-resistant clinical isolates of Acinetobacter baumannii J Vila, J Ruiz, P Goni, A Marcos, T Jimenez de Anta Antimicrobial agents and chemotherapy 39 (5), 1201-1203, 1995 | 298 | 1995 |
Detection of mutations in parC in quinolone-resistant clinical isolates of Escherichia coli J Vila, J Ruiz, P Goni, MT De Anta Antimicrobial agents and chemotherapy 40 (2), 491-493, 1996 | 295 | 1996 |